[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Drug Treatments for Asthma and Chronic Obstructive Pulmonary Disease
that Do Not Use Chlorofluorocarbons

Many products that do not use chlorofluorocarbons (CFC) are already available for the treatment of asthma and chronic obstructive pulmonary disease. These products aren't necessarily "official" direct alternatives to CFC Metered Dose Inhalers but may in many patients serve as a useful medication that could replace the need for a particular CFC Metered Dose Inhaler. FDA will determine official alternatives by using the criteria established through notice-and-comment rulemaking, as it has done with albuterol.

Information regarding FDA's approval of these products is available here. As FDA approves new non-CFC drugs, we will add that information to this page.

Drugs are listed in alphabetical order by active moiety, with specific brands available listed under each active moiety. What is an active moiety? An active moiety is the part of a drug that makes the drug work the way it does. Many different drug products may be marketed with the same active moiety.

Back to Top     Back to MDI Info

Date created: March 31, 2005

horizonal rule